209 related articles for article (PubMed ID: 12598798)
1. Pharmacoepidemiology and rheumatic diseases: 2001-2002.
Solomon DH; Avorn J
Curr Opin Rheumatol; 2003 Mar; 15(2):122-6. PubMed ID: 12598798
[TBL] [Abstract][Full Text] [Related]
2. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
[No Abstract] [Full Text] [Related]
3. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
Nurmohamed MT; van Halm VP; Dijkmans BA
Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
[TBL] [Abstract][Full Text] [Related]
4. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
5. [Can we treat with modern antirheumatics? Costs of NSAID treatment].
Bolten WW
Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457
[No Abstract] [Full Text] [Related]
6. [Not Available].
Krüger K
Dtsch Med Wochenschr; 2017 Nov; 142(23):1773-1774. PubMed ID: 29145683
[No Abstract] [Full Text] [Related]
7. [Treatment of rheumatoid arthritis].
Bolten WW
MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
[No Abstract] [Full Text] [Related]
8. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
Bolten WW
MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
[TBL] [Abstract][Full Text] [Related]
10. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoepidemiology and rheumatic disorders.
Chan KA; Hernandez-Diaz S
Rheum Dis Clin North Am; 2004 Nov; 30(4):835-50, vii. PubMed ID: 15488696
[TBL] [Abstract][Full Text] [Related]
12. [Coxibs].
Bolten WW; Krüger K
Z Rheumatol; 2016 Aug; 75(6):595-8. PubMed ID: 27418054
[No Abstract] [Full Text] [Related]
13. [Not Available].
Korsten P; Müller GA
Dtsch Med Wochenschr; 2017 Nov; 142(23):1775-1777. PubMed ID: 29145684
[No Abstract] [Full Text] [Related]
14. Key developments in rheumatology.
Panthakalam S; Pal B
Practitioner; 2000 Dec; 244(1617):1024-6, 1029-32. PubMed ID: 11220170
[No Abstract] [Full Text] [Related]
15. Antirheumatic medications in pregnancy and breastfeeding.
Birru Talabi M; Clowse MEB
Curr Opin Rheumatol; 2020 May; 32(3):238-246. PubMed ID: 32205567
[TBL] [Abstract][Full Text] [Related]
16. Contribution of pharmacoepidemiological studies to the evaluation of treatment-related adverse events.
Suissa S
Joint Bone Spine; 2006 Dec; 73(6):627-8. PubMed ID: 17126057
[No Abstract] [Full Text] [Related]
17. Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy.
Chan KK; Bass AR
Rheum Dis Clin North Am; 2024 May; 50(2):337-357. PubMed ID: 38670731
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
Ferraccioli G; De Santis M; Tolusso B
Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
[TBL] [Abstract][Full Text] [Related]
19. [By what means does the rheumatic patient with gastrointestinal risks fare best?].
Einecke D
MMW Fortschr Med; 2007 Mar; 149(10):18. PubMed ID: 17408040
[No Abstract] [Full Text] [Related]
20. [The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
Krüger K
MMW Fortschr Med; 2005 Aug; 147(31-32):28-30. PubMed ID: 16128193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
